GlassScriptPhysician profile
Martin Manzo
NPI 1750360244
$820.26
in general payments reported to CMS, 2019-2025
21 companies · $18.58 in 2025
The $18.58 reported for 2025 was less than what a typical Chiropractor provider received nationally (typical 2025 total: $40.91).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $56.68 · 2020: $169 · 2021: $292 · 2022: $70.81 · 2023: $213 · 2025: $18.58.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $231.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $231.11 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Jazz Pharmaceuticals INC. | $158.25 | 2021-2025 | Xywav |
| Novo Nordisk INC | $151.94 | 2019-2021 | |
| Takeda Pharmaceuticals U.S.A., INC. | $87.44 | 2021-2023 | Trintellix |
| Amarin Pharma, INC. | $74.55 | 2020-2021 | |
| Eisai INC. | $41.67 | 2020-2021 | |
| Avanos Medical | $32.48 | 2022-2023 | Genvisc 850 Sodium Hyaluronate |
| Clarus Therapeutics INC. | $29.70 | 2021 | |
| Aytu Biopharma, INC. | $28.54 | 2019 | |
| Exact Sciences Corporation | $28.04 | 2023 | Cologuard Collection Kit |
| Abbott Laboratories | $20.12 | 2023 | Freestyle Libre 3 |
| Bausch Health US, LLC | $18.88 | 2023 | Aplenzin |
| Corcept Therapeutics | $18.56 | 2023 | Korlym |
| Janssen Pharmaceuticals, INC | $16.42 | 2021 | |
| Vivus LLC | $15.80 | 2021 | |
| Shire North American Group INC | $14.97 | 2019 |
Show all 21 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Arbor Pharmaceuticals, INC. | $14.90 | 2021 | |
| Paratek Pharmaceuticals, INC. | $14.45 | 2021 | |
| Alexion Pharmaceuticals, INC. | $13.76 | 2020 | |
| Csl Behring | $13.53 | 2021 | |
| Bioventus LLC | $13.23 | 2021 | |
| Harmony Biosciences LLC | $13.03 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Martin Manzo listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.